Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.3%

3 terminated/withdrawn out of 41 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

39%

16 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

25 recruiting

Enrollment Performance

Analytics

N/A
17(42.5%)
Phase 3
8(20.0%)
Phase 4
8(20.0%)
Phase 2
7(17.5%)
40Total
N/A(17)
Phase 3(8)
Phase 4(8)
Phase 2(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials
NCT04789057Phase 4Active Not Recruiting

Atorvastatin Effect on Reduction of COPD Exacerbations

Role: collaborator

NCT06466031Not ApplicableRecruiting

Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]

Role: collaborator

NCT06011889Phase 2Recruiting

Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

Role: collaborator

NCT06297096Phase 3Recruiting

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Role: collaborator

NCT05978206Phase 2Recruiting

Study of the Effectiveness of Treatment of Sarcopenia With the Use of a Medicinal Product (Nandrolone), Comprehensive Physiotherapy and Diet

Role: collaborator

NCT06688331Phase 2Recruiting

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

Role: collaborator

NCT06885268Phase 3Recruiting

Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery

Role: collaborator

NCT07195149Phase 3Recruiting

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Role: collaborator

NCT06878729Not ApplicableRecruiting

Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

Role: collaborator

NCT06527027Not ApplicableRecruiting

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

Role: collaborator

NCT06293157Not ApplicableRecruiting

Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease

Role: collaborator

NCT07254572Phase 4Recruiting

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

Role: collaborator

NCT05271162Phase 3Recruiting

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Role: collaborator

NCT07094984Not ApplicableRecruiting

Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract

Role: collaborator

NCT06529081Not ApplicableRecruiting

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

Role: collaborator

NCT07111221Not ApplicableRecruiting

Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss

Role: collaborator

NCT07088705Not ApplicableEnrolling By Invitation

Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa

Role: collaborator

NCT06652698Not ApplicableNot Yet Recruiting

Early Supplementation for Cow's Milk Allergy Prevention

Role: collaborator

NCT07013552Not ApplicableNot Yet Recruiting

Oritavancin for CIED Infections With MDR Gram-positive Cocci

Role: collaborator

NCT05966675Not ApplicableRecruiting

Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI

Role: collaborator